Dr Reddys Labs Consolidated December 2024 Net Sales at Rs 8,381.20 crore, up 15.81% Y-o-Y Jan 28 2025 01:32 PM Hold Dr Reddys Laboratories; target of Rs 1245: KR Choksey Jan 27 2025 12:36 PM ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

After hours: January 29 at 6:02:40 PM EST Loading Chart for IDXX ...

After hours: January 30 at 4:01:42 PM EST Loading Chart for MLAB ...

Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 31,732.31 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...

Two of the most notable examples of this in recent years are Actavis (now owner of Allergan and to take Allergan's name globally) and Gilead. Actavis was a generics giant whose rise mirrors the ...

Lambda Labs, a Nvidia partner, has lost its chief operating officer to a little-known company building hardware for the AI industry. Mitesh Agrawal told Business Insider he stepped into a new role ...

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...